BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18204158)

  • 1. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
    Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of protein acetylation in inflammatory lung diseases.
    Ito K; Charron CE; Adcock IM
    Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
    Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ
    N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone acetylation and deacetylation: importance in inflammatory lung diseases.
    Barnes PJ; Adcock IM; Ito K
    Eur Respir J; 2005 Mar; 25(3):552-63. PubMed ID: 15738302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin.
    Biswas S; Rahman I
    Mol Nutr Food Res; 2008 Sep; 52(9):987-94. PubMed ID: 18327875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression.
    Rahman I; Marwick J; Kirkham P
    Biochem Pharmacol; 2004 Sep; 68(6):1255-67. PubMed ID: 15313424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylation: an important mechanism in inflammatory lung diseases.
    Adcock IM; Ito K; Barnes PJ
    COPD; 2005 Dec; 2(4):445-55. PubMed ID: 17147010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase-2 and airway disease.
    Barnes PJ
    Ther Adv Respir Dis; 2009 Oct; 3(5):235-43. PubMed ID: 19812111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of histone deacetylases in asthma and allergic diseases.
    Bhavsar P; Ahmad T; Adcock IM
    J Allergy Clin Immunol; 2008 Mar; 121(3):580-4. PubMed ID: 18234319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD unwound.
    Shapiro SD
    N Engl J Med; 2005 May; 352(19):2016-9. PubMed ID: 15888704
    [No Abstract]   [Full Text] [Related]  

  • 15. Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling.
    Yao H; Yang SR; Kode A; Rajendrasozhan S; Caito S; Adenuga D; Henry R; Edirisinghe I; Rahman I
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1151-5. PubMed ID: 17956299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
    Kirkham P; Rahman I
    Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and redox regulation of lung inflammation in COPD.
    Rahman I; Adcock IM
    Eur Respir J; 2006 Jul; 28(1):219-42. PubMed ID: 16816350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC inhibitors in models of inflammation-related tumorigenesis.
    Glauben R; Sonnenberg E; Zeitz M; Siegmund B
    Cancer Lett; 2009 Aug; 280(2):154-9. PubMed ID: 19101082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathogenesis of chronic obstructive pulmonary disease, steroid resistance and the place of theophylline in the treatment].
    Bayram H
    Tuberk Toraks; 2009; 57(1):115-24. PubMed ID: 19533448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code.
    Calao M; Burny A; Quivy V; Dekoninck A; Van Lint C
    Trends Biochem Sci; 2008 Jul; 33(7):339-49. PubMed ID: 18585916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.